妊娠后7-15年母亲高血压风险:来自胎盘的线索
前瞻性队列研究纳入490名孕妇,评估子痫前期相关的胎盘/胎膜外膜表现与妊娠期血压及随访7-15年后2期高血压的关联。发现壁性增生与随访2期高血压风险升高相关(aOR=2.7,95%CI 1.1-6.6),妊娠期血压中度升高且伴壁性增生者风险更高(aOR=4.5,95%CI 1.6-12.5)。作者认为这些胎盘表现有助于对妊娠期血压中度升高女性进行远期高血压风险分层。
要点
- 壁性增生与随访2期高血压风险升高相关(aOR=2.7,95%CI 1.1-6.6)。
- 妊娠期血压中度升高且伴壁性增生者随访2期高血压风险更高(aOR=4.5,95%CI 1.6-12.5)。
- 子痫前期相关胎盘/胎膜外膜表现有助于妊娠期血压中度升高女性的远期高血压风险分层。
核心结论
- 子痫前期相关的胎盘/胎膜外膜表现有助于对妊娠期血压中度升高的女性进行远期高血压风险分层。
研究设计与样本
- 前瞻性队列研究,在美国密歇根州5个社区的52家产前诊所招募孕16-27周女性(1998-2004年),本样本纳入490名有详细胎盘评估及随访7-15年心血管健康评估的亚队列女性。
主要发现
- 排除妊娠期高血压(慢性、子痫前期、妊娠期)女性后,壁性增生与随访2期高血压相关(aOR=2.7,95%CI 1.1-6.6),蜕膜血管无改变/异常与随访2期高血压相关(aOR=1.7,95%CI 0.8-3.4,未达统计学显著)。
- 妊娠期血压中度升高且伴壁性增生的女性随访2期高血压风险升高(aOR=4.5,95%CI 1.6-12.5)。
- 妊娠期血压中度升高且伴蜕膜血管无改变/异常的女性随访2期高血压风险升高(aOR=2.6,95%CI 1.1-5.9)。
关键数值与推荐
- 2期高血压定义为随访时收缩压≥140 mmHg和/或舒张压≥90 mmHg,或使用降压药物。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess whether pre-eclampsia (PE)-related placental/extraplacental membrane findings are linked to moderately elevated blood pressure (BP) in pregnancy and later-life hypertension. DESIGN: Prospective cohort. SETTING: 52 prenatal clinics, 5 Michigan communities. SAMPLE: The POUCH Study recruited women at 16-27 weeks' gestation (1998-2004) and studied a sub-cohort in depth. This sample (n = 490) includes sub-cohort women with detailed placental assessments and cardiovascular health evaluations 7-15 years later in the POUCHmoms follow-up study. METHODS: PE-related placental/extraplacental membrane findings (i.e. mural hyperplasia, unaltered/abnormal vessels or atherosis in decidua; infarcts) were evaluated in relation to pregnancy BP and odds of Stage 2 hypertension at follow up using weighted polytomous regression. Follow-up hypertension odds also were compared in three pregnancy BP groups: normotensives (referent) and moderately elevated BP with or without PE-related placental/extraplacental membrane findings. MAIN OUTCOME MEASURES: Stage 2 hypertension (SBP ≥140 mmHg and/or DBP ≥90 mmHg, or using antihypertensive medications) at follow up. RESULTS: After excluding women with pregnancy hypertension (i.e. chronic, PE, gestational), mural hyperplasia and unaltered/abnormal decidual vessels were each associated with Stage 2 hypertension at follow up: adjusted odds ratio (aOR) = 2.7, 95% CI 1.1-6.6, and aOR = 1.7 (95% CI 0.8-3.4), respectively. Women with moderately elevated BP in pregnancy and evidence of mural hyperplasia or unaltered/abnormal decidual vessels had greater odds of Stage 2 hypertension at follow up: aOR = 4.5 (95% CI 1.6-12.5 and aOR = 2.6, 95% CI 1.1-5.9, respectively. CONCLUSIONS: PE-related placental/extraplacental membrane findings help risk-stratify women with moderately elevated BP in pregnancy for later development of hypertension. TWEETABLE ABSTRACT: Placental findings associated with mother's risk of later-life hypertension.
引用
- Holzman CB, Senagore P, Xu J, et al. Maternal risk of hypertension 7-15 years after pregnancy: clues from the placenta. BJOG. 2020. PMID: 32931608. doi:10.1111/1471-0528.16498
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。